Yuyama Manufacturing Co., Ltd. manufactures and supplies medical formulation and dispensing equipment. It specializes in the production of formulation and dispensing equipment for hospitals, clinics, and pharmacies. The firm's products include tablet packing machines, vail filling machines, ampul dispensing systems, and compact powder packing machines. It also offers technology solutions, such as risk management and hospital logistic management systems. The company was founded in November 1964 and is headquartered in Toyonaka, Japan.

Hisamitsu Pharmaceutical Co., Ltd, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a Taiwanese company located in Taipei. The firm manufactures and markets pharmaceuticals.

Zyno Medical is an IV infusion pump manufacturer. Zyno Medical manufactures and sells our own infusion pump line and IV sets.

B. Braun Medical is a medical device manufacturing company that specializes in infusion therapy and pain management. It focuses on developing, manufacturing, and marketing medical products and services to the healthcare industry. B. Braun Medical was founded in 1839 and headquartered in Bethlehem, Pennsylvania.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Adare Pharmaceuticals, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ.

Equashield Medical Ltd. is a company headquartered in Migdal Tefen, Israel, with subsidiaries in the United States, that manufactures and wholesales medical devices. It was founded in 2009 by Eric Shem-Tov, he has been the CEO since the inception date.

Shandong Xundakang Veterinary Medicine Co., Ltd, established on 1999-09-29, Business scope includes production,Sales:powder/Premix/Powder/Terminally sterilized small volume injection(Contains Chinese herbal extracts)/Terminally Sterilized Bulk Non-intravenous Injectables(Contains Chinese herbal extracts)/oral solution(Contains Chinese herbal extracts),Granules(Contains Chinese herbal extracts),Chinese medicine extraction(Licorice Extract,Licorice Extract),disinfectant(solid,liquid);Economic and Trade Consulting(Does not include futures,finance,Securities Advisory);import and export trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Weiqiang Medical Technology Co., Ltd., established on 2016-05-03, Business scope includes technology development,technical consulting,Achievement transfer:medical technology,Class I medical device,Class III medical devices;Production,wholesale,retail:Class I medical device,Class III medical devices;Import and export of goods and technology(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license)(Except those involving the implementation of special access management measures stipulated by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenyang Zhonghai Biotechnology Development Co., Ltd., established on 1998-10-06, Business scope includes chemicals,Research and development of traditional Chinese medicine,Related Technical Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Domantis Ltd. develops antibody molecules. Domantis Ltd. offers dual targeting human domain antibodies, which are used against cytokine targets for inflammatory diseases, tumour antigens present on the same tumour cells, and tumour growth/angiogenic factors for solid tumours; human domain antibodies with tailored serum half-life that are customized to achieve the desired therapeutic effect; human domain antibodies for diverse therapeutic targets, which are suited to inhibit receptor targets; and injectable and non-injectable human domain antibodies that treat diseases of the lung, as well as disorders of the gastro-intestinal tract.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Hengyang Sanggu Medical Robot Co., Ltd., established on 2015-09-29, Business scope includes technology development of robots,production and sales;Invest in robotics research projects with self-owned funds(Not to engage in deposit taking,Fundraising collection,entrusted loan,issue notes,Loans and other national financial supervision and fiscal credit business);Domestic Trade(Do not Dangerous,Monitor);Goods and technology import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Matsushita Electronics Corp. develops and manufactures electronic products. Its products include plasma TVs, DVD players, and digital cameras. It is a subsidiary of Matsushita Electric Industrial Co. Ltd. The company is headquartered in Osaka, Japan.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Shandong Zhongwang Hengli Environmental Technology Co., Ltd., established on 2011-03-02, Business scope includes environmental technology development,technical consulting,Technology promotion and application;Noise Control Engineering,Design of Environmental Engineering,construction,technology development,technical consulting;Environmental protection facility operation service;Sewage Treatment and Its Reuse;Water-saving management and technical consulting services;Atmospheric Environment,Water Environment,Soil Environmental Pollution Prevention and Control Services;Production,Sales:Special equipment for environmental protection,water saving equipment,Water purification equipment,biologics,Microbial agents,fungicide,Corrosion and scale inhibitors;wholesale,retail:energy saving equipment,Instrumentation,hardware products,electric equipment,building materials,steel,Chemical Products(Free of Hazardous Chemicals);Mechanical equipment professional cleaning service;Import and export business;Professional contracting of building mechanical and electrical installation engineering,Construction labor subcontracting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)